Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07444385
PHASE1
A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects
Official title: An Open-Label, Randomized, Single-Dose, Two-Sequence, Two-Period Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Volunteers Under Fed Conditions
Key Details
Gender
MALE
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2026-02-26
Completion Date
2026-05-08
Last Updated
2026-03-03
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-116, AD-1161
Single-dose oral administration of AD-116 or AD-1161, according to randomized sequence.
Locations (1)
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea